Terrascend Corp
CNSX:TER
Intrinsic Value
TerrAscend Corp. produces and sells medical cannabis products. [ Read More ]
The intrinsic value of one TER stock under the Base Case scenario is 2.53 CAD. Compared to the current market price of 2.8 CAD, Terrascend Corp is Overvalued by 10%.
Valuation Backtest
Terrascend Corp
Run backtest to discover the historical profit from buying and selling TER stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Terrascend Corp
Current Assets | 122m |
Cash & Short-Term Investments | 29.8m |
Receivables | 22.4m |
Other Current Assets | 69.8m |
Non-Current Assets | 579.6m |
PP&E | 245.3m |
Intangibles | 330m |
Other Non-Current Assets | 4.3m |
Current Liabilities | 137.9m |
Accounts Payable | 44.3m |
Accrued Liabilities | 521k |
Other Current Liabilities | 93.1m |
Non-Current Liabilities | 244.9m |
Long-Term Debt | 152.6m |
Other Non-Current Liabilities | 92.3m |
Earnings Waterfall
Terrascend Corp
Revenue
|
247.8m
USD
|
Cost of Revenue
|
-146.3m
USD
|
Gross Profit
|
101.5m
USD
|
Operating Expenses
|
-125.2m
USD
|
Operating Income
|
-23.7m
USD
|
Other Expenses
|
-306.2m
USD
|
Net Income
|
-329.9m
USD
|
Free Cash Flow Analysis
Terrascend Corp
TER Profitability Score
Profitability Due Diligence
Terrascend Corp's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
Score
Terrascend Corp's profitability score is 31/100. The higher the profitability score, the more profitable the company is.
TER Solvency Score
Solvency Due Diligence
Terrascend Corp's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Score
Terrascend Corp's solvency score is 39/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TER Price Targets Summary
Terrascend Corp
According to Wall Street analysts, the average 1-year price target for TER is 3.34 CAD .
Shareholder Return
TER Price
Terrascend Corp
Average Annual Return | 92.85% |
Standard Deviation of Annual Returns | 255.49% |
Max Drawdown | -93% |
Market Capitalization | 868.7m CAD |
Shares Outstanding | 310 255 920 |
Percentage of Shares Shorted | 0.61% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
TerrAscend Corp. produces and sells medical cannabis products. The company is headquartered in Mississauga, Ontario and currently employs 742 full-time employees. The company went IPO on 2017-05-03. The firm operates in Pennsylvania, New Jersey, Michigan and California, licensed cultivation and processing operations in Maryland and licensed production in Canada. The company operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its markets. The company provides range of product selection to both the medical and legal adult-use markets. The firm owns several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc, and others. Gage is a cannabis brand and operator, that provides cannabis products to consumers in the state of Michigan and Canada. Arise Bioscience Inc., is a manufacturer and distributor of hemp-derived products; Ilera Healthcare (Ilera), Pennsylvania’s medical cannabis cultivator, processor and dispenser
Contact
IPO
Employees
Officers
The intrinsic value of one TER stock under the Base Case scenario is 2.53 CAD.
Compared to the current market price of 2.8 CAD, Terrascend Corp is Overvalued by 10%.